“Benchtop to Bedside,” known as B2B, is designed to give research scientists, clinicians, and other interested parties the basic information necessary to assess the market potential of basic science research discoveries in healthcare.

Carolyn Green, Executive Director, Strategic Investments, Pfizer Worldwide R&D will give a “Voice from the Trenches” talk and discuss the value of biotech development in an academic setting.

No RSVP Needed

FacebookTwitter